Literature DB >> 24782015

GnRH antagonist-based protocols for in vitro fertilization.

David Reichman1, Zev Rosenwaks.   

Abstract

In this chapter we elaborate on the intricacies of employing GnRH antagonists for prevention of the endogenous luteinizing hormone surge during IVF. Several practical aspects of implementing a GnRH antagonist-based stimulation protocol are described; selection of the correct dose, choosing when to start the antagonist, programming of cycle starts, selection of the appropriate gonadotropins, and triggering of final oocyte maturation are elucidated.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24782015     DOI： 10.1007/978-1-4939-0659-8_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  4 in total

1.  One thousand seventy-eight autologous IVF cycles in women 45 years and older: the largest single-center cohort to date.

Authors:  Vinay Gunnala; Mohamad Irani; Alexis Melnick; Zev Rosenwaks; Steven Spandorfer
Journal:  J Assist Reprod Genet       Date:  2017-11-16       Impact factor: 3.412

2.  Replacing single frozen-thawed euploid embryos in a natural cycle in ovulatory women may increase live birth rates compared to medicated cycles in anovulatory women.

Authors:  Alexis P Melnick; Robert Setton; Logan D Stone; Nigel Pereira; Kangpu Xu; Zev Rosenwaks; Steven D Spandorfer
Journal:  J Assist Reprod Genet       Date:  2017-06-24       Impact factor: 3.412

3.  Natural frozen embryo transfer with hCG booster leads to improved cycle outcomes: a retrospective cohort study.

Authors:  David E Reichman; Claire R Stewart; Zev Rosenwaks
Journal:  J Assist Reprod Genet       Date:  2020-03-20       Impact factor: 3.412

4.  Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles.

Authors:  Vinay Gunnala; Alexis Melnick; Mohamad Irani; David Reichman; Glenn Schattman; Owen Davis; Zev Rosenwaks
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.